Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel-Reference-Cited by-同舟云学术

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel

Published:2003-12 Issue:3 Volume:91 Page:584-590
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Dizon Don S,Dupont Jakob,Anderson Sibyl,Sabbatini Paul,Hummer Amanda,Aghajanian Carol,Spriggs David

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference17 articles.

1. Cancer statistics 2003;Jemal;CA Cancer J Clin,2003

2. Response of patients in phase II studies of chemotherapy in ovarian cancer;Blackledge;Br J Cancer,1989

3. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds;Gore;Gynecol Oncol,1990

4. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991

5. Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma;Dizon;J Clin Oncol,2002

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints;Expert Opinion on Investigational Drugs;2019-08-30

2. Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer;International Journal of Gynecological Cancer;2018-01

3. Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy;Archives of Gynecology and Obstetrics;2017-09-07

4. Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer;The Journal of Allergy and Clinical Immunology: In Practice;2017-01

5. Adjunct Histamine Blockers as Premedications to Prevent Carboplatin Hypersensitivity Reactions;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2016-04-04